Quality of life as a therapeutic objective in the management of hepatic encephalopathy and the potential role of rifaximin-α

OBJECTIVE: Quality of life (QoL) is impaired in patients with hepatic encephalopathy and rifaximin-α can improve QoL within 6 months. This study assessed the importance of QoL as a therapeutic objective in hepatic encephalopathy management; whether QoL is routinely assessed in hepatic encephalopathy...

Descripción completa

Detalles Bibliográficos
Autores principales: Deltenre, Pierre, Labenz, Christian, Schuchmann, Marcus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams And Wilkins 2021
Materias:
Short Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8734632/
https://www.ncbi.nlm.nih.gov/pubmed/34402475
http://dx.doi.org/10.1097/MEG.0000000000002273

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8734632/
https://www.ncbi.nlm.nih.gov/pubmed/34402475
http://dx.doi.org/10.1097/MEG.0000000000002273

Ejemplares similares